A detailed history of Northern Trust Corp transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 19,273 shares of ARMP stock, worth $45,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,273
Previous 19,292 0.1%
Holding current value
$45,291
Previous $80,000 33.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.4 - $3.9 $45 - $74
-19 Reduced 0.1%
19,273 $53,000
Q1 2024

May 14, 2024

SELL
$2.81 - $4.18 $247 - $367
-88 Reduced 0.45%
19,292 $80,000
Q1 2022

May 13, 2022

BUY
$3.9 - $6.32 $75,582 - $122,481
19,380 New
19,380 $95,000

Others Institutions Holding ARMP

About Armata Pharmaceuticals, Inc.


  • Ticker ARMP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,144,700
  • Market Cap $84.9M
  • Description
  • Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...
More about ARMP
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.